期刊文献+

口服避孕药与子代健康 被引量:4

原文传递
导出
摘要 本文就国内外对口服避孕药是否造成染色体异常、影响胚胎发育和导致先天性畸形等出生缺陷疾病(如先天性心脏病、肢体短缺畸形、尿道和前列腺畸形、神经系统畸形、食管闭锁、多/并指(趾)畸形、变态反应性疾病、女性胎儿男性化、唐氏综合征等)进行了综述。
出处 《中国优生与遗传杂志》 2010年第3期11-13,共3页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献35

  • 1蒋涛,李幼平.口服避孕药对妇女健康及子代的影响[J].中国妇幼健康研究,2007,18(1):80-83. 被引量:12
  • 2Nora JJ, Nora AH, Blu J, et al. Exogenous progestogen and estrogen implicated in birth defects[ J]. JAMA,1978,240:837 - 843.
  • 3Wiseman RA, Dodds - Smith IC. Cardiovascular birth defects and antenatal exposure to female sex hormones:a reevaluation of some base data[ J]. Teratology,1984,30:359 - 370.
  • 4Spira N, Goujard J, Huel G, Rumeau - Rouquette C. Etude teratogene des hormones sexuelles. Premiers resuhats d'une enquete epidemiologique portant sur 20000 femmes[ J]. Rev Med Fr, 1972,41:2683.
  • 5Pardthaisong T, Gray RH. In utero exposure to steroid contraceptives and outcome of pregnancy[ J ]. Am J Epidemiol, 1991,134:795 - 803.
  • 6Bracken MB. Oral contraception and congenital malformations in offspring:a review and meta analysis of the prospective studies[ J ]. Obstet Gynecol, 1990,76:552 - 557.
  • 7Jaffe B, Shye D, Harlap S, et al. Health, growth, and sexual development of teenagers exposed in utero to medroxyprogesterone acetate [ J]. Paediat Perinat Epidemiol, 1990,4 : 184 - 195.
  • 8Janerich DT, Piper JM, Glebatis DM. Oral contraceptives and congenital limb - reduction defects [ J ]. N Engl J Med, 1974,291:697 - 700.
  • 9Rothman KJ,Louik C. Oral contraceptives and birth defects[J]. N Engl J Med, 1978,299:522 - 524.
  • 10Royal College of General Practitioners. Oral contraception study, the outcome of pregnancy in former oral contraceptive users[ J]. Br J Obstet Gynaecol,1976,83:608 - 616.

二级参考文献25

  • 1[1]Simpson JL, Phillips OP. Spermicides,Hormonal contraception and congenital malformations. Advances in Contracepton, 1990, 6:141~1471.
  • 2[2]Bracken MB,Oral contraceptive and congenital malformation in offspring:A review and meta-analysis of the prospective studies,Obstetrics and Gynaecology, 1990,76 : 552~557.
  • 3Thomeycroft I H.Evolution of progestins:Focus on the novel progestin drospirenone[J].J Reprod Med,2002,47(11 Suppl):975-984.
  • 4Kulier R,Helmerhorst F M,MalWa N.et al.Effectiveness and acceptability of progestogens in combined oral contraceptives-a systematic review[J].Reprod Health,2004,1(1):1.
  • 5Novotua M,Huvar I,BIalla O.Long-term use of combined hormonal contraception-myths and reality[J].Ceska Gynekol,2002,67(5):297-304.
  • 6Bassol S,Alvarado G,Arreola R G,et al.A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women[J].Contraception,2003,67(5):367-372.
  • 7Poindexter A.The emerging use of the 20-micmg oral contraceptive[J].Fertil Steril,2001,75(3)457-465.
  • 8Low L F,Anstey K J.Hormone replacement therapy and cognitive performance in postmenpopausal women-a review by cognitive domain[J].Neurosci BiobehavRev,2006,30(1):66-84.
  • 9Bnrknlan R T.Reproductive hormones and cancer:Ovarian and colon cancer[J].Obstet Gynecol Clin North Am,2002,29(3):527-540.
  • 10Lourdes I,Carme V,Francisde Z.Discontinuous low-dose flutamide-mefformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism:Normalizing effects on CRP,TNF-αand the neutrophil/lymphocyte ratio[J].Human Reproduction,2006,21(2):451-456.

共引文献14

同被引文献32

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部